Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Good
|
|
New words:
AB, alemtuzumab, APB, blood, CAMPATH, constitute, Countervailing, customary, Czech, decree, deliberate, earlier, eligible, enacted, environment, ETI, exact, Extraterritorial, feature, FSC, Greece, impractical, injection, intercompany, jurisdiction, main, matter, monitoring, mono, multinational, notification, Poland, Portugal, practice, professional, prohibited, protein, public, quantify, quantitative, reallocated, reception, repatriate, repatriation, Repeal, Republic, resolve, sensitivity, solid, subsidy, unasserted, World, WTO
Removed:
advanced, al, Alameda, alleged, array, breached, captionPignone, consenting, consulting, County, decided, educate, equitable, forecasting, HAE, heart, Historically, implemented, intracompany, label, lanthanum, lawsuit, mg, percent, precise, presently, promotion, relationship, rescinding, responsible, RG, Seprafilm, sought, stockholder, today, unmet
Filing tables
Filing exhibits
Related press release
GZTR similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
Written Statement of the Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, I, the undersigned Chief Financial Officer of Genzyme Corporation (the "Company"), hereby certify that the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2004 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| /s/ MICHAEL S. WYZGA Michael S. Wyzga Chief Financial Officer | ||
November 9, 2004 |